The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
We need to measure the particle size of a moisture-sensitive powder. We would like to use dry analysis on our laser-diffraction system, but the particles are fragile and we're struggling to get robust results. Is wet measurement with a nonaqueous solvent the only option?
PharmTech's monthly newsletter, Equipment and Processing Report, reviews the Editor's Picks for the February 2012 edition from ACS Valves and G-Con.
More collaboration and expanded oversight aim to compel manufacturers to follow GMPs.
Pharma announces plans for the year ahead at annual JPMorgan Global Healthcare conference.
A nickel's worth of free advice to the competition could come at the expense of your bottom line.
In Part I of a three-part article, the authors discuss what constitutes an impurity and the potential sources of impurities in APIs and finished drug products.
Industry optimism is on the rise for 2012.
New educational programs are key to the industry's future and to safe, available drugs.
The Asian nation is strategizing to take the lead over its regional competitors in pharmaceutical exports.
New product reviews for February 2012.
Debottlenecking downstream mAb purification.
ICH Q8, Q9, and Q10 support and implications for the future.
Experts discuss solutions for filter bacterial retention and related challenges. Contains online bonus material.
A technical forum featuring Catalent Pharma Solutions, SAFC, and Neuland Laboratories.
The scandal surrounding Servier's diabetes drug, Mediator, continues to unravel in France and could have implications for the whole pharmaceutical industry as the country scrutinises its regulatory systems.
This column will address some of the questions on how single use systems are sterilized by gamma irradiation and what documentation may be requested by regulators.
The author describes an equation that can be used to define the Quality relationship between a contract manufacturing organization and a client, including how to factor in both party's needs and regulatory commitments.
The author examines the opportunities and positioning of contract service providers.
We bring industry experts together to discuss the importance of self-administration and what injection technologies are best suited to this cause.
Understanding equipment design and product-contact surfaces enables strong cleaning action.
PharmTech's monthly newsletter, Equipment and Processing Report, reviews the Editor's Picks for the January 2012 edition from ACS Valves and Terra Universal.
The pharmaceutical industry has a history of developing innovative medicines and novel drug-delivery systems, but not all of its manufacturing processes use cutting-edge technologies. Demands to increase productivity in fill–finish lines are fueling the arguments of proponents of robotic automation to expedite manufacturing.
I work in a quality control laboratory and use a pH meter with a single-junction reference probe to test samples taken from various pharmaceutical (drug) production lines. The probe I use has a six-month warranty. It slowly stops working after just a couple weeks. I am replacing it once a month. We make sure to store it correctly according to the manufacturer's specifications and even use probe cleaner at the end of each shift to ensure that it stays clean. What can I do to increase the lifespan to at least cover the warranty period?
The US Pharmacopeia announced a draft standard containing best practices for ensuring that drugs can be traced to their original manufacturer, are not counterfeited or adulterated, and can be transported to their intended destination without compromising quality.
USP Releases Guidelines on Ensuring the Integrity of the Pharmaceutical Supply Chain.
